COUMATRAK PROTHROMBIN TIME (PT) TEST
Report
- Report Number
- 2937793-1992-00001
- Event Type
- Injury
- Date Received
- September 22, 1992
- Date of Event
- July 29, 1992
- Report Date
- August 13, 1992
- Manufacturer
- BIOTRAK, INC.
- Product Code
- GJS
- Adverse Event
- Yes
- Report Source
- Distributor report
- Reporter Location
- AL, US
- Reporter Occupation
- UNKNOWN
Narratives
THE PATIENT, A 55 YEAR OLD FEMALE WAS EVALUATED BY THE PHYSICIAN IN THE OFFICE. SIGNIFICANT PAST MEDICAL HISTORY INCLUDED A MITRAL VALVE TREPLACEMENT, HYPEWRTENSION AND DIABETES MELLITUS. THE PATIENT HAD STARTED ANTICOAGULATION THERAPY IN DECEMBER, 1990. USING THE COUMATRAK DEVICE IN THE OFFICE, THE PHYSICIAN OBTAINED A PROTHROMBIN TIME MEASUREMENT OF 27 SECONDS ON 7/29/92. THE PHYSICIAN IMMEDIATELY STOPPRD THE COUMADIN (DAILY DOSAGE OF 7.5 MG) WITH INSTRUCTIONS TO THE PATIENT TO RESTART THERAPY AT 5 MG DAILY THREE DAYS LATER (7/31/92).THE PATIENT WAS ADMITTED TO THE HOSPITAL TWO DAYS AFTER EVALUATION WITH A "STROKE AFTER THROWING A CLOT." PROTHROMBIN TIME MEASURED IN THE EMERGENCY ROOM WAS 11 SECONDSINVALID DATA - REGARDING SINGLE USE LABELING OF DEVICE. PATIENT MEDICAL STATUS PRIOR TO EVENT: UNKNOWN. INVALID DATA - REGARDING MULTIPLE PATIENT INVOLVEMENT.INVALID DATA - ON DEVICE SERVICE/MAINTENANCE. NO DATA - REGARDING DATE LAST SERVICED. SERVICE PROVIDED BY: INVALID DATA. INVALID DATA - SERVICE RECORDS AVAILABILITY. INVALID DATA - REGARDING WHETHER EVENT PRESENTS IMMINENT HAZARD. INVALID DATA - WHETHER DEVICE USED AS LABELED/INTENDED. DEVICE WAS EVALUATED AFTER THE EVENT. METHOD OF EVALUATION: NONE OR UNKNOWN. RESULTS OF EVALUATION: NONE OR UNKNOWN. CONCLUSION: NONE OR UNKNOWN. CERTAINTY OF DEVICE AS CAUSE OF OR CONTRIBUTOR TO EVENT: YES. CORRECTIVE ACTIONS: NONE OR UNKNOWN. INVALID DATA - ON DEVICE DESTROYED/DISPOSED OF STATUS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | COUMATRAK PROTHROMBIN TIME (PT) TEST | GJS | BIOTRAK, INC. | REA. CART; P10213 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 55 YR | Other |